MU Researchers Identify Potential Cause of Elevated Nighttime Blood Pressure among OSA Patients
Cell secretions may be key to diagnosing and treating nocturnal hypertension.
Cell secretions may be key to diagnosing and treating nocturnal hypertension.
Together, the companies will offer a comprehensive point-of-care portfolio for diabetes management.
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
The number of people living with diabetes and its prevalence are growing in all regions of the world.
Read MoreCandidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.
Read MoreCurrent and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read MoreThe conclusion to our three-part series exploring the value of diagnostics.
Read MorePart two of a three-part roundtable discussing the value of diagnostics.
Read MoreThe DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read MoreThe biennial ASCP vacancy survey has captured a profession in transition.
Read MoreResearchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read MoreThe concept of prevention is expanding, notes principal investigator Christie Ballantyne, MD, director of the Center for Cardiovascular Disease Prevention at The Methodist Hospital.
Read MoreResearchers have found that high levels of triglycerides (blood fats) are the strongest risk factor for the most common type of stroke in older women.
Read MoreThe study found success in utilizing a new method of delivery of a potent biotechnology anti-inflammatory therapeutic. Pictured is a patient dialing a phone an hour after treatment, something he’d previously been unable to do after his stroke.
Read MoreThe research, conducted using Thermo Scientific mass spectrometers, provided insight into key areas of stroke evaluation and treatment.
Read MoreNew research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death.
Read MoreA new statistical model could be used to predict an individuals lifetime risk of stroke, finds a study from the Childrens Hospital Informatics Program (CHIP).
Read MoreElevated nonfasting triglyceride levels, previously associated with an increased risk for heart attack, also appear to be associated with an increased risk for ischemic stroke, according to a study in JAMA.
Read More